ScholarGate
المساعد

قارن الطرق

راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.

الرقابة الدوائية PRR/ROR×فحص نفاذية خلايا كـاكـو-2×
المجالعلم الأدويةعلم الأدوية
العائلةProcess / pipelineProcess / pipeline
سنة النشأة20021989
صاحب الطريقةArne Melander and colleaguesIngrid Hidalgo
النوعsafety signal detectionabsorption screening
المصدر التأسيسيSzarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗
الأسماء البديلةPRR, ROR, signal detection, adverse event monitoringCaco-2 assay, intestinal permeability, ADME screening
ذات صلة33
الملخصProportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.
ScholarGateمجموعة البيانات
  1. v1
  2. 2 المصادر
  3. PUBLISHED
  1. v1
  2. 2 المصادر
  3. PUBLISHED

انتقل إلى البحث تنزيل الشرائح

ScholarGateقارن الطرق: Pharmacovigilance PRR/ROR · Caco-2 Permeability. استُرجع بتاريخ 2026-06-19 من https://scholargate.app/ar/compare